STAGE III PROSTATE CANCER AJCC V8
Clinical trials for STAGE III PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising prostate cancer trial pulled before it even started
Disease control TerminatedThis study was designed to see if adding the immunotherapy drug pembrolizumab to standard hormone therapy and radiation could improve outcomes for men with high-risk prostate cancer that hasn't spread. The trial was withdrawn before enrolling any participants, so no results are a…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 17, 2026 03:15 UTC
-
Gene test guides prostate cancer treatment: less or more hormone therapy?
Disease control OngoingThis study tests whether adjusting hormone therapy based on a patient's genetic risk score can improve outcomes for high-risk prostate cancer. For those with a low genetic risk, a shorter course of hormone therapy (12 months instead of 24) is compared to standard care. For those …
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 17, 2026 03:12 UTC
-
Immunotherapy plus chemo shows promise against tough cancers
Disease control OngoingThis early-phase trial is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can help people with rare, aggressive small cell or neuroendocrine cancers of the bladder or prostate that have spread. About 15 participants will receive the combinatio…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
Bladder lift may cut incontinence after prostate surgery
Symptom relief TerminatedThis study tests whether adding a procedure called vesicopexy (restoring the bladder to its normal position) during robotic prostate cancer surgery helps men regain bladder control faster and improves quality of life. About 196 men with early-stage prostate cancer will be randoml…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 17, 2026 03:12 UTC
-
Prostate cancer treatment may harm your heart – new study investigates
Knowledge-focused OngoingThis study looks at how certain hormone therapies for prostate cancer affect the heart. It compares two drugs, leuprolide and relugolix, given alongside radiation. The goal is to understand why some men develop heart problems and find ways to predict and reduce that risk. About 9…
Matched conditions: STAGE III PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC